SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-21-308040
Filing Date
2021-10-26
Accepted
2021-10-26 16:46:06
Documents
5
Period of Report
2021-12-03

Document Format Files

Seq Description Document Type Size
1 DEF 14A d249150ddef14a.htm DEF 14A 434133
2 GRAPHIC g249150g1023022556895.jpg GRAPHIC 6390
3 GRAPHIC g249150g1023022557348.jpg GRAPHIC 1428
4 GRAPHIC g249150g1023022557629.jpg GRAPHIC 7178
5 GRAPHIC g249150g1023022558083.jpg GRAPHIC 3779
  Complete submission text file 0001193125-21-308040.txt   461916
Mailing Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134
Business Address 355 ALHAMBRA CIRCLE SUITE 801 CORAL GABLES FL 33134 (305) 529-2522
CATALYST PHARMACEUTICALS, INC. (Filer) CIK: 0001369568 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-33057 | Film No.: 211349190
SIC: 2834 Pharmaceutical Preparations